Document Detail

Oral minocycline in the treatment of vitiligo--a preliminary study.
MedLine Citation:
PMID:  20597950     Owner:  NLM     Status:  MEDLINE    
For effective treatment of vitiligo, it is as important to arrest the progression of the disease, as it is to induce repigmentation. Epidermal oxidative stress has been documented in vitiligo patients, and there is much support for a free-radical-mediated damage as an initial pathogenic event in melanocyte degeneration in vitiligo. Minocycline possesses a wide repertoire of anti-inflammatory, immunomodulatory, and free-radical scavenging actions in addition to their well-characterized antimicrobial effects. Recently, it has been shown that minocycline can rescue melanocytes from oxidative stress in vitro. Minocycline 100 mg was tried in this study to elucidate its role in arresting disease activity. Thirty-two patients with gradually progressive (slow spreading) vitiligo were enrolled in this study. The patients were advised to take minocycline 100 mg once daily. In 29 patients, the progression of the disease was arrested, and only three patients showed development of new lesions and/or enlargement of existing lesions. Ten patients showed arrest of further depigmentation after 4 weeks of treatment. Thus, minocycline offers a unique and potentially powerful approach to the management of arresting the activity of the disease. The present study showed the effectiveness of minocycline in the treatment of vitiligo. Further controlled studies should be undertaken to confirm its efficacy.
Davinder Parsad; Amrinderjit Kanwar
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Dermatologic therapy     Volume:  23     ISSN:  1529-8019     ISO Abbreviation:  Dermatol Ther     Publication Date:    2010 May-Jun
Date Detail:
Created Date:  2010-07-05     Completed Date:  2010-10-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9700070     Medline TA:  Dermatol Ther     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  305-7     Citation Subset:  IM    
Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Anti-Inflammatory Agents / administration & dosage*
Middle Aged
Minocycline / administration & dosage*
Vitiligo / drug therapy*
Young Adult
Reg. No./Substance:
0/Anti-Inflammatory Agents; 10118-90-8/Minocycline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of recalcitrant Darier's disease with electron beam therapy.
Next Document:  The efficacy of nicotinamide gel 4% as an adjuvant therapy in the treatment of cutaneous erosions of...